Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 2,344 startups that have raised more than $5 billion in funding, generated more than $2.7 billion in revenue, and created more than 126,000 total jobs. 

Our startups

Be inspired. Search our startups.

Clear  
SUN bioscience

SUN bioscience is the first company to standardize organoid cultures. Organoids are mini-organs grown from stem cells with potential from personalized drug screening to transplants. Our first focus is to bring retinal organoids to clinics with the long-term goal to transplant photoreceptors for retinal degeneration, a set of diseases with neither treatments nor cures. While establishing the GMP protocols, we service pharmaceutical companies for their drug screening needs.
We standardize organoids for personalized medicine.

Connect with SUN bioscience

SUN bioscience

2016

Sub industry

Diagnostics

Additional Industries
Healthcare Delivery
Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.